Equities research analysts at StockNews.com assumed coverage on shares of Avinger (NASDAQ:AVGR – Get Free Report) in a research report issued on Tuesday. The brokerage set a “hold” rating on the medical device company’s stock.
Avinger Stock Up 7.5 %
Shares of Avinger stock opened at $1.04 on Tuesday. The stock’s fifty day moving average is $1.16 and its two-hundred day moving average is $2.19. The company has a market capitalization of $1.77 million, a PE ratio of -0.06 and a beta of 1.17. Avinger has a 52 week low of $0.90 and a 52 week high of $6.55.
Avinger (NASDAQ:AVGR – Get Free Report) last posted its quarterly earnings results on Thursday, August 8th. The medical device company reported ($2.82) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.43) by ($2.39). The firm had revenue of $1.85 million during the quarter, compared to analyst estimates of $2.55 million. As a group, research analysts anticipate that Avinger will post -4.69 earnings per share for the current year.
Hedge Funds Weigh In On Avinger
About Avinger
Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.
Featured Articles
- Five stocks we like better than Avinger
- How to Find Undervalued Stocks
- S&P 500 Hitting Resistance: These 3 Stocks Offer the Best Upside
- Where to Find Earnings Call Transcripts
- Nike’s Post-Earnings Drop Presents a Buying Opportunity
- How to Read Stock Charts for Beginners
- Microsoft’s Targeted Upside Might Be Too Good to Ignore
Receive News & Ratings for Avinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avinger and related companies with MarketBeat.com's FREE daily email newsletter.